Association of IL28B Polymorphism with Fibrosis, Liver Inflammation, Gender Respective Natural History of Hepatitis C Virus in Egyptian Patients with Genotype 4

被引:6
作者
Youssef, Samar Samir [1 ]
Abbas, Eman Abd El-Razek [1 ]
Abd el Aal, Asmaa Mostafa [1 ]
el Zanaty, Taher [2 ]
Seif, Sameh Mohamed [3 ]
机构
[1] Natl Res Ctr, Microbial Biotechnol Dept, Cairo 11231, Egypt
[2] Cairo Univ, Fac Med, Dept Internal Med, Cairo, Egypt
[3] Natl Hepatol & Trop Med Res Inst, Cairo, Egypt
关键词
GENETIC-VARIATION; SPONTANEOUS CLEARANCE; PROGRESSION; INFECTION; THERAPY; SUSCEPTIBILITY;
D O I
10.1089/jir.2013.0036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The polymorphism of interleukin 28B (IL28B) rs12979860 is associated with spontaneous and treatment-induced clearance in hepatitis C virus (HCV) genotype 4 (G4). However, there is no information on its interaction with gender, moreover its association with intrahepatic inflammation in North Africans is not studied and its association with fibrosis in North Africans (especially Egyptians) is controversial. This study aims to explore the association between the minor allele of the IL28B rs12979860 polymorphism with gender, fibrosis and necroinflammation in Egyptian G4 HCV patients. IL28B rs12979860 was genotyped in 224 individuals, including 100 healthy controls and 124 consecutive patients with chronic HCV. Results showed (1) IL28B rs12979860 minor alleles associated with susceptibity to chronic HCV mainly in men not women, (2) no association between IL28B rs12979860 with fibrosis and necroinflammation activity, (3) the IL28B rs12979860 TT genotype associated with severe fibrosis in women only and with the necroinflammation activity in men using a recessive model. In conclusion, the IL28B rs12979860 polymorphism is not associated with fibrosis and liver inflammation in Egyptian HCV G4. Nonetheless, the TT genotype of IL28B rs12979860 polymorphism affects the natural history of each gender independently.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 26 条
[1]   IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4 [J].
Antaki, N. ;
Bibert, S. ;
Kebbewar, K. ;
Asaad, F. ;
Baroudi, O. ;
Alideeb, S. ;
Hadad, M. ;
Abboud, D. ;
Sabah, H. ;
Bochud, P. -Y. ;
Negro, F. .
JOURNAL OF VIRAL HEPATITIS, 2013, 20 (01) :59-64
[2]   IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C [J].
Asselah, Tarik ;
De Muynck, Simon ;
Broet, Philippe ;
Masliah-Planchon, Julien ;
Blanluet, Maud ;
Bieche, Ivan ;
Lapalus, Martine ;
Martinot-Peignoux, Michelle ;
Lada, Olivier ;
Estrabaud, Emilie ;
Zhang, Qian ;
El Ray, Ahmed ;
Vidaud, Dominique ;
Ripault, Marie-Pierre ;
Boyer, Nathalie ;
Bedossa, Pierre ;
Valla, Dominique ;
Vidaud, Michel ;
Marcellin, Patrick .
JOURNAL OF HEPATOLOGY, 2012, 56 (03) :527-532
[3]   IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes [J].
Bochud, Pierre-Yves ;
Bibert, Stephanie ;
Kutalik, Zoltan ;
Patin, Etienne ;
Guergnon, Julien ;
Nalpas, Bertrand ;
Goossens, Nicolas ;
Kuske, Lorenz ;
Muellhaupt, Beat ;
Gerlach, Tillman ;
Heim, Markus H. ;
Moradpour, Darius ;
Cerny, Andreas ;
Malinverni, Raffaele ;
Regenass, Stephan ;
Dollenmaier, Guenter ;
Hirsch, Hans ;
Martinetti, Gladys ;
Gorgiewski, Meri ;
Bourliere, Marc ;
Poynard, Thierry ;
Theodorou, Ioannis ;
Abel, Laurent ;
Pol, Stanislas ;
Dufour, Jean-Francois ;
Negro, Francesco .
HEPATOLOGY, 2012, 55 (02) :384-394
[4]   Pathogenesis, diagnosis and management of hepatitis C [J].
Boyer, N ;
Marcellin, P .
JOURNAL OF HEPATOLOGY, 2000, 32 :98-112
[5]   Interleukin-28 and hepatitis C virus genotype-4: Treatment-induced clearance and liver fibrosis [J].
Derbala, Moutaz ;
Rizk, Nasser ;
Shebl, Fatima ;
Alkaabi, Saad ;
Eldweik, Nazeeh ;
John, Anil ;
Sharma, Manik ;
Yaqoob, Rafie ;
Almohanadi, Muneera ;
Butt, Mohammed ;
Alejji, Khaled .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (47) :7003-7008
[6]  
Dustin LB, 2007, ANNU REV IMMUNOL, V25, P71, DOI 10.1146/annurev.immunol.25.022106.141602
[7]   Association of IL28B SNP With Progression of Egyptian HCV Genotype 4 Patients to End Stage Liver Disease [J].
El-Awady, Mostafa K. ;
Mostafa, Lotiaf ;
Tabll, Ashraf A. ;
Abdelhafez, Tawfeek H. ;
El Din, Noha G. Bader ;
Zayed, Naglaa ;
El Shenawy, Reem ;
El Abd, Yasmin ;
Hasan, Reham M. ;
Zaghlol, Hosam ;
El Khayat, Hesham ;
Aziz, Ashraf O. Abdel .
HEPATITIS MONTHLY, 2012, 12 (04) :271-277
[8]   Role of Interleukin 28B rs12979860 C/T Polymorphism on the Histological Outcome of Chronic Hepatitis C: Relationship with Gender and Viral Genotype [J].
Falleti, Edmondo ;
Bitetto, Davide ;
Fabris, Carlo ;
Cussigh, Annarosa ;
Fornasiere, Ezio ;
Cmet, Sara ;
Fumolo, Elisa ;
Bignulin, Sara ;
Fontanini, Elisabetta ;
Cerutti, Andrea ;
Minisini, Rosalba ;
Pirisi, Mario ;
Toniutto, Pierluigi .
JOURNAL OF CLINICAL IMMUNOLOGY, 2011, 31 (05) :891-899
[9]   The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt [J].
Frank, C ;
Mohamed, MK ;
Strickland, GT ;
Lavanchy, D ;
Arthur, RR ;
Magder, LS ;
El Khoby, T ;
Abdel-Wahab, Y ;
Ohn, EA ;
Anwar, W ;
Sallam, I .
LANCET, 2000, 355 (9207) :887-891
[10]   Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance [J].
Ge, Dongliang ;
Fellay, Jacques ;
Thompson, Alexander J. ;
Simon, Jason S. ;
Shianna, Kevin V. ;
Urban, Thomas J. ;
Heinzen, Erin L. ;
Qiu, Ping ;
Bertelsen, Arthur H. ;
Muir, Andrew J. ;
Sulkowski, Mark ;
McHutchison, John G. ;
Goldstein, David B. .
NATURE, 2009, 461 (7262) :399-401